Cargando…
Pharmacogenetics of the Primary and Metastatic Osteosarcoma: Gene Expression Profile Associated with Outcome
Osteosarcoma (OS) is the most common malignant bone tumor in children and adolescents. In recent decades, OS treatment has reached a plateau and drug resistance is still a major challenge. Therefore, the present study aimed to analyze the expression of the genes related to pharmacogenetics in OS. Th...
Autores principales: | Trujillo-Paolillo, Alini, Tesser-Gamba, Francine, Seixas Alves, Maria Teresa, Filho, Reynaldo Jesus Garcia, Oliveira, Renato, Petrilli, Antonio Sergio, Toledo, Silvia Regina Caminada |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10059037/ https://www.ncbi.nlm.nih.gov/pubmed/36982681 http://dx.doi.org/10.3390/ijms24065607 |
Ejemplares similares
-
CYP genes in osteosarcoma: Their role in tumorigenesis, pulmonary metastatic microenvironment and treatment response
por: Trujillo-Paolillo, Alini, et al.
Publicado: (2017) -
Biopsy Path Contamination in Primary Bone Sarcomas
por: Garcia, Jairo Greco, et al.
Publicado: (2019) -
Pharmacogenomics and Pharmacogenetics in Osteosarcoma: Translational Studies and Clinical Impact
por: Hattinger, Claudia Maria, et al.
Publicado: (2020) -
Pharmacogenetic analysis of high-dose methotrexate treatment in children with osteosarcoma
por: Hegyi, Marta, et al.
Publicado: (2016) -
Pharmacogenetics of chemotherapy treatment response and -toxicities in patients with osteosarcoma: a systematic review
por: Hurkmans, Evelien G. E., et al.
Publicado: (2022)